Anharmonic Coupled Cluster Spectroscopic Characterization of 5-Cyano-1,3-cyclopentadiene
Symmetry · 19.11.2026 · 18 (11) · 1935
DOI: 10.3390/sym18111935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Symmetry, online erschienen am 19.11.2026. Verfasst von Ryan C. Fortenberry und 1 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NASA, Mississippi Center for Supercomputing Research, Chapman University.
Abstract (Originalsprache)
The quantum chemically computed rotational constants of Cs 5-cyano-1,3-cyclopentadiene (5-cyano-CPD, c-C5H5CN) are 6600.8, 2126.3, and 1789.8 MHz. Those computed in the same manner for the astronomically known 1-cyano-CPD agree with the experiment to within 0.3% or less, providing confidence in the guidance of the experimental examination of 5-cyano-CPD, which could aid in possible astronomical searches. The C≡N stretch fundamental for 5-cyano-CPD at 2268.6 cm−1 is less intense and higher in frequency than that of the same motion in cyanated polycyclic aromatic hydrocarbons (CN-PAHs) at 2223 cm−1. The C≡N stretch of 1-cyano-CPD is more intense, but this isomer’s fundamental at 2245.8 cm−1 is higher than most CN-PAHs, which max out below 2230 cm−1.
Förderung
- NASA
- Mississippi Center for Supercomputing Research
- Chapman University
Zitieren
APA
Fortenberry, R. C., & Esposito, V. J. (2026). Anharmonic Coupled Cluster Spectroscopic Characterization of 5-Cyano-1,3-cyclopentadiene. Symmetry, 18(11), 1935. https://doi.org/10.3390/sym18111935
Vancouver
Fortenberry RC, Esposito VJ. Anharmonic Coupled Cluster Spectroscopic Characterization of 5-Cyano-1,3-cyclopentadiene. Symmetry. 2026;18(11):1935. doi:10.3390/sym18111935
BibTeX
@article{Fortenberry2026,
author = {Fortenberry, Ryan C. and Esposito, Vincent J.},
title = {Anharmonic Coupled Cluster Spectroscopic Characterization of 5-Cyano-1,3-cyclopentadiene},
journal = {Symmetry},
year = {2026},
volume = {18},
number = {11},
pages = {1935},
doi = {10.3390/sym18111935}
}
EUVIMED